| Position | Action |
|---|---|
| Retest of the $220-$222 zone | Trim 10-15% position to harvest gains and reduce AI capex concentration |
Morgan Stanley at $216 represents a mid-cycle entry point in a structural growth story driven by AI-era capital markets dominance, exceptional 62% EPS growth, and a supportive Fed backdrop—not an exhausted top after a 168% three-year run.
| Indicator | Value | Signal |
|---|---|---|
| 10 EMA | 214.05 | bullish |
| 50 SMA | 214.82 | neutral |
| 200 SMA | 183.84 | bullish |
| Price vs 200 SMA | +17.7% | bullish |
| RSI (14) | 52.68 | neutral |
| MACD Line | 0.00 | neutral |
| MACD Signal Line | -0.21 | neutral |
| MACD Histogram | +0.21 | bullish |
| Bollinger Upper (2σ) | 226.33 | neutral |
| Bollinger Middle (20 SMA) | 214.82 | neutral |
| Bollinger Lower (2σ) |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
Maintain Hold; tactical trim on strength, await breakout confirmation before committing capital
Hold is the correct call given genuinely symmetric risk/reward (~7%/16% upside to $232/$250 versus ~6%/15% downside to $203/$184). Neither BUY (which would commit capital before confirmation) nor SELL (which would crystallize losses on a name with intact long-term uptrend and exceptional fundamentals) is justified. Adopt $209-$210 soft warning zone rather than 50 SMA at $214.82 to avoid routine whipsaw exits during normal volatility.
The July peak and subsequent pullback is a textbook bull flag consolidation, not distribution or topping
↩ rebuts: “Bear's failed July breakout = distribution/exhaustion claim”
· concedes: Single failed July breakout is a real data point, not fabricated; 168% three-year return is a factual past return; Some valuation metrics appear elevated on surface (PEG 2.03); RSI at 52 lacks immediate momentum confirmation (though bull frames this as attractive entry, not warning)
MS is a late-cycle trap where the easy money has been made, with failed breakout technicals, rich valuations at peak cyclical margins, episodic AI deal flow that isn't a durable moat, and social sentiment conspicuously absent—warranting SELL or HOLD with no new position initiation at current levels.
· concedes: Q2 2026 numbers were genuinely strong with 27.4% revenue growth and 57.6% net income growth; Anthropic $15B mandate is a real achievement and PR win for the franchise; Buybacks are a real structural tailwind, just insufficient alone to justify current valuation; Macro environment today is indeed Goldilocks; Higher lows are forming in the $211 to $213 area
→ vs conservative: The HOLD stance is a 'coward's middle path' that guarantees participation in none of the upside while still absorbing downside risk if it comes; waiting for technical confirmation means buying higher or missing the move entirely
→ vs conservative: 'Slightly overvalued' framing after a 168% three-year run is backwards-looking; forward P/E of 15.87 is reasonable for 62% EPS growth and 3.19x P/B is appropriate for a transformed business mix
→ vs conservative: Failed breakouts in strong uptrends are often continuation patterns; declining VWMA during a basing phase is absorption, not distribution
→ vs neutral: 'Balanced risk/reward' framing is incorrect — the structure is explicitly asymmetric with 6% downside versus 7-15% upside, making it a clear buy
→ vs neutral: 'Waiting for resolution' means missing the move; buying at a fresh MACD cross near zero is one of the highest-probability momentum entries available
| 203.32 |
| neutral |
| ATR (14) | 6.35 | neutral |
| VWMA (20-day) | 212.55 | bullish |
| Close | 216.33 | — |
| 07-15 High | 230.98 | — |
| 07-29 Low | 201.83 | — |
| 06-18 Swing High | 221.95 | — |
| 07-09 High | 220.90 | — |
| Intraday Low | 211.81 | — |
Support: 211.81 · 203.32 · 183.84 | Resistance: 220.9 · 221.95 · 226.33 · 230.98
Morgan Stanley is in a neutral-to-cautiously-bullish consolidation phase after a sharp mid-July selloff from $230.98 to $201.83, now trading at $216.33 slightly above key short-term moving averages (10 EMA: 214.05, 50 SMA: 214.82). The technical picture shows a fresh bullish MACD cross (histogram +0.21), RSI rebuilding from oversold at 52.68, and price 17.7% above the 200 SMA at $183.84 confirming long-term uptrend integrity. Key resistance lies at $221.95–$226.33 while critical support sits at $203.32 (lower Bollinger band); the current HOLD recommendation awaits confirmation via a high-volume breakout above $221.95 with RSI >60.
Market Cap
$340.07B
P/E Ratio (TTM)
17.47
Forward P/E
15.87
PEG Ratio
2.03
Price/Book
3.19
EPS (TTM)
$12.38
Forward EPS
$13.63
Dividend Yield
2.15%
Beta
1.209
Revenue (Q2 2026)
$19.88B
Revenue Growth YoY
+27.4%
Net Income (Q2 2026)
$5.58B
Net Income Growth YoY
+57.6%
EPS (Q2 2026)
$3.46
EPS Growth YoY
+62.4%
Gross Profit (TTM)
$68.21B
Profit Margin
25.90%
Operating Margin
41.57%
Return on Equity (ROE)
17.97%
Return on Assets (ROA)
1.35%
Total Assets
$1,675.06B
Total Liabilities
$1,557.62B
Total Equity
$117.44B
Common Stock Equity
$106.58B
Book Value per Share
$67.80
Long-term Debt
$391.46B
Cash & Equivalents
$123.04B
52-Week High
$232.25
52-Week Low
$141.03
50-Day Average
$214.65
200-Day Average
$184.68
Debt-to-Equity Ratio
517
Current Ratio
1.999
Share Buybacks (5 quarters)
$8.4B
Tangible Book Value
$83.60B
Strengths
Concerns
Morgan Stanley is a high-quality capital markets company with strong fundamentals, trading at a market cap of $340.07B. The company delivered exceptional Q2 2026 results with 27.4% revenue growth and 57.6% net income growth, backed by a 17.97% ROE and 25.90% profit margin. While the diversified business model (Institutional Securities, Wealth Management, Investment Management) provides stability, the stock trades near its 52-week high at premium valuation metrics (P/E 17.47x, P/B 3.19x), warranting a HOLD recommendation for current investors and BUY-on-pullbacks for new entrants.